Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeted degradation of ⍺-synuclein aggregates in Parkinson’s disease using the AUTOTAC technology
Jihoon Lee, Ki Woon Sung, Eun-Jin Bae, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Targeted protein degradation directly engaging lysosomes or proteasomes
Jiseong Kim, Insuk Byun, Do Young Kim, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 7, pp. 3253-3272
Open Access | Times Cited: 24
Expanding the horizons of targeted protein degradation: A non-small molecule perspective
Xiaowei Huang, Fengbo Wu, Jing Ye, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 6, pp. 2402-2427
Open Access | Times Cited: 16
Focusing on mitochondria in the brain: from biology to therapeutics
Nanshan Song, Shuyuan Mei, Xiang-Xu Wang, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 14
Targeting selective autophagy and beyond: From underlying mechanisms to potential therapies
Wei Ma, Yingying Lü, Xin Jin, et al.
Journal of Advanced Research (2024) Vol. 65, pp. 297-327
Open Access | Times Cited: 9
Aquaporin-4 and Parkinson’s Disease
К. В. Лапшина, И. В. Екимова
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1672-1672
Open Access | Times Cited: 7
Targeted protein degradation in CNS disorders: a promising route to novel therapeutics?
Sandra Kuemper, Andrew G. Cairns, Kristian Birchall, et al.
Frontiers in Molecular Neuroscience (2024) Vol. 17
Open Access | Times Cited: 6
Molecular Insights into Aggrephagy: Their Cellular Functions in the Context of Neurodegenerative Diseases
Valentín Cóppola-Segovia, Fulvio Reggiori
Journal of Molecular Biology (2024) Vol. 436, Iss. 15, pp. 168493-168493
Open Access | Times Cited: 5
Proteolysis-targeting drug delivery system (ProDDS): integrating targeted protein degradation concepts into formulation design
Yu Chen, Fengyuan Liu, Samira Pal, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 19, pp. 9582-9608
Closed Access | Times Cited: 5
Effects of the PI3K/Akt/HO-1 pathway on autophagy in a sepsis-induced acute lung injury mouse model
Jing Tian, Yanan Li, Xing Mao, et al.
International Immunopharmacology (2023) Vol. 124, pp. 111063-111063
Open Access | Times Cited: 11
α-Synuclein pathology as a target in neurodegenerative diseases
Hye-Jin Park, Tae‐In Kam, Valina L. Dawson, et al.
Nature Reviews Neurology (2024)
Closed Access | Times Cited: 4
Advances in Aggrephagy: Mechanisms, Disease Implications, and Therapeutic Strategies
Haixia Zhuang, Xinyu Ma
Journal of Cellular Physiology (2025) Vol. 240, Iss. 1
Closed Access
Fibrinogen degradation products exacerbate alpha-synuclein aggregation by inhibiting autophagy via downregulation of Beclin1 in multiple system atrophy
Huanzhu Liu, Ruoyang Yu, Muwei Zhang, et al.
Neurotherapeutics (2025), pp. e00538-e00538
Open Access
New strategies to enhance the efficiency and precision of drug discovery
Qi An, Liang Huang, Chuan Wang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
R406 and its structural analogs reduce SNCA/α-synuclein levels via autophagic degradation
Chao Zhong, Xiaoge Gao, Qi Chen, et al.
Autophagy (2025)
Open Access
Targeting neurodegenerative disease-associated protein aggregation with proximity-inducing modalities
Ruixin Ge, Miao Chen, Qingchao Li, et al.
Acta Pharmacologica Sinica (2025)
Closed Access
Targeted degradation of α-synuclein prevents PFF-induced aggregation
Bill Carton, Géraldine Gelders, Gajanan Sathe, et al.
(2025)
Open Access
Targeted protein degradation for the treatment of Parkinson’s disease: Advances and future perspective
Roshanak Amirian, Mehdi Azadi Badrbani, Hossein Derakhshankhah, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115408-115408
Open Access | Times Cited: 9
Targeting protein aggregation for the treatment of neurodegenerative diseases
Qingchao Li, Wei Pan, Jun Zhou, et al.
Medicine Plus (2024) Vol. 1, Iss. 1, pp. 100005-100005
Open Access | Times Cited: 3
Interfering with aggregated α-synuclein in advanced melanoma leads to a major upregulation of MHC class II proteins
Claudia Fokken, Ivan Silbern, Orr Shomroni, et al.
Melanoma Research (2024) Vol. 34, Iss. 5, pp. 393-407
Closed Access | Times Cited: 3
Targeted protein degradation: current molecular targets, localization, and strategies
Dimanthi Pliatsika, Cindy Blatter, Rainer Riedl
Drug Discovery Today (2024), pp. 104178-104178
Open Access | Times Cited: 2
The autophagy–lysosome pathway: a potential target in the chemical and gene therapeutic strategies for Parkinson’s disease
Fengjuan Jiao, Lingyan Meng, Kang Du, et al.
Neural Regeneration Research (2024) Vol. 20, Iss. 1, pp. 139-158
Open Access | Times Cited: 2
The mechanisms, hallmarks, and therapies for brain aging and age-related dementia
Shiyun Jin, Wenping Lü, Juan Zhang, et al.
Science Bulletin (2024)
Closed Access | Times Cited: 2
Targeted protein degradation with bifunctional molecules as a novel therapeutic modality for Alzheimer's disease & beyond
Carl Alexander Sandhof, Helen C. Murray, M. Catarina Silva, et al.
Neurotherapeutics (2024), pp. e00499-e00499
Closed Access | Times Cited: 2
Targeted degradation of SNCA/α-synuclein aggregates in neurodegeneration using the AUTOTAC chemical platform
Jihoon Lee, Dabin Yoon, Ki Woon Sung, et al.
Autophagy (2023) Vol. 20, Iss. 2, pp. 463-465
Closed Access | Times Cited: 6
Executive Summary of 2023 International Conference of the Korean Dementia Association (IC-KDA 2023): A Report From the Academic Committee of the Korean Dementia Association
Geon Ha Kim, Jaeho Kim, Won‐Seok Choi, et al.
Dementia and Neurocognitive Disorders (2024) Vol. 23, Iss. 2, pp. 75-75
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top